WHR Global Publica Ask the Expert, Relatório Internacional de Benchmark de Auxílios e Diárias para 2023

A WHR Global molda as políticas dos clientes para garantir que as ofertas de benefícios sejam competitivas no mercado

MILWAUKEE, July 17, 2023 (GLOBE NEWSWIRE) — A WHR Global (WHR), líder da indústria global de realocação de funcionários, anunciou a publicação do “Ask the Expert” (Pergunta ao Especialista), Relatório Internacional de Benchmark de Auxílios e Diárias para 2023.

A missão da WHR é fornecer aos clientes serviços de realocação superiores e, para isso, precisamos estar em sintonia com o custo de vida global. Para isso, criamos o Ask the Expert, Relatório Internacional de Benchmark de Auxílios e Diárias para 2023, um guia abrangente para entender o verdadeiro custo de vida, não apenas em uma cidade, mas em muitas cidades do mundo.

“Com base na minha experiência pessoal como ex-expatriado residente na Suíça e ex-coordenador de relocação, trago um profundo entendimento dos desafios e complexidades da realocação internacional”, disse Sean Thrun, Gerente de Iniciativas Estratégicas da WHR. “Este relatório de referência e conhecimento em primeira mão equipa a WHR com a capacidade de fornecer informações e orientações valiosas para as equipes de mobilidade, permitindo que elas naveguem nas complexidades das atribuições globais com mais eficiência.”

O Relatório inclui 8,8 milhões de preços em 11.000 cidades. Os benchmarks the preços por país incluem preços de aluguel de unidades de 1 e 3 quartos dentro e fora dos centros das cidades, custo mensal de serviços públicos comuns, transporte local e muito mais. Com o conhecimento das realidades básicas do custo de vida as equipes de realocação podem criar soluções escaláveis, ajudando as empresas a fazer mudanças mais produtivas, facilitando muito a realocação do funcionário.

O Relatório permite que as empresas “confiram a opinião” sobre seus auxílios e diárias, independentemente de optarem pela administração de valores fixos globais ou variáveis locais. Caso as equipes de mobilidade global achem que os auxílios e diárias oferecidos aos seus funcionários são inferiores à média do país, contate a WHR hoje para uma consulta gratuita, inclusive detalhes do relatório de benchmark por cidade.

As equipes de mobilidade global podem usar este Relatório, que abrange 99 países, para comparar o seguinte:

  • Auxílios mensais de moradia para atribuições e passageiros,
  • Auxílios mensais de utilidades públicas para atribuições e passageiros,
  • Auxílios mensais de transporte para atribuições e passageiros,
  • Diárias de transporte para viagens e visitas de busca de moradia, e
  • Diárias de refeições para viagens e visitas de busca de moradia.

Seja você um gerente de realocação ou um líder de negócios, o investimento no Relatório Internacional de Benchmark de Auxílios e Diárias para 2023 hoje pode ajudá-lo a tomar as decisões mais informadas para o seu orçamento de realocação e políticas de benefícios para funcionários.

Para mais detalhes e fazer o download completo, clique em 2023 Allowances & Per Diems Benchmark Report “Ask an Expert”.

O benchmark Ask the Expert, Relatório Internacional de Benchmark de Auxílios e Diárias para 2023, destina-se apenas a fins informativos.

Sobre a WHR Global

A WHR Global (WHR) é uma empresa global de gestão de relocação privada, orientada para o cliente, distinguida pela sua melhor prestação de serviços e tecnologia proprietária de ponta. A WHR tem escritórios nos Estados Unidos, Suíça e Cingapura. Com sua taxa de retenção de clientes de 100% na última década, o WHR continua a se posicionar como líder confiável na relocação global de funcionários. A WHR vive por sua visão e paixão por Advancing Lives Forward™ e Making the Complex Simple. Para mais informação sobre a WHR, visite https://www.whrg.com/, ou siga-nos no LinkedIn ou Twitter.

Contato:
Sean Thrun, Gerente de Iniciativas Estratégicas
+1-262-746-1314
Sean.Thrun@whrg.com

GlobeNewswire Distribution ID 8874927

Vytelle Expands to Brisbane, Australia with Sixteenth Global Bovine In Vitro Fertilisation Laboratory

BRISBANE, Australia,, July 13, 2023 (GLOBE NEWSWIRE) — Vytelle, a precision livestock company, is progressing on their five-year plan to provide accessible, hormone-free, bovine in vitro fertilisation to producers across the globe. Announced today, Vytelle has expanded to Brisbane, Australia with its sixteenth global laboratory.

Vytelle’s integrated technology platform combines Vytelle ADVANCE, a breakthrough in vitro fertilisation (IVF) technology, with Vytelle SENSE, an animal performance data capture system, and Vytelle INSIGHT, an artificial intelligence based genetic analytics engine.  The platform provides progressive cattle producers the technology to make reliable data-driven mating decisions that improve the predictability of genetic progress, replicating the right genetics faster.

The Brisbane-based, Australia laboratory brings accessibility to modern reproduction technology like never before to Australia’s eastern states’ beef herds. Vytelle’s hormone-free in vitro fertilisation process, including their proprietary media, will deliver high-quality embryos to producers allowing them to make more valuable calves, faster to maximise sustainability.

“Vytelle is the fastest growing bovine IVF company in the world,” commented Kerryann Kocher, CEO of Vytelle. She continued, “We are thrilled to open our doors in Brisbane, positioning Vytelle to serve 70% of the total beef herd in Australia from this location.”

 Vytelle has a long history in Australia through its Vytelle SENSE phenotypic data capture technology to measure and select for feed efficiency. With this investment, Vytelle is positioned to help Australian producers improve efficiencies and make faster genetic progress across the supply chain to consistently market more efficient and sustainable beef. “The large-scale adoption of IVF will be driven by the successful use of frozen embryos,” stated Andrew Donoghue, Regional Manager for Australia and New Zealand. He continued, “Unlike other technologies, the Vytelle system allows us to deliver frozen results producers can count on, providing reliable IVF to herds historically underserved with fresh programs.”

The Australian-based team is serving beef and dairy producers with on-farm ovum pick-ups immediately. Visit www.vytelle.com or contact Andrew Donoghue at andrew.donoghue@vytelle.com or +61 428 442 1555 to accelerate your herd’s genetic progress today.

Attachment

Andrew Donoghue
Vytelle
+61 428 442 1555
andrew.donoghue@vytelle.com

GlobeNewswire Distribution ID 8874359

What Nigerians need to know about Dominica’s Citizenship by Investment Programme

Roseau, July 13, 2023 (GLOBE NEWSWIRE) — Nigeria is currently facing economic challenges, despite having the largest economy in Africa. The country’s debt grew a staggering 500 per cent under the former President, Muhammadu Buhari. The World Bank revised Nigeria’s gross domestic product (GDP) earlier this year, in the recent Nigeria Development Update (NDU).

The NDU report is released biannually by the World Bank and evaluates Nigeria’s current economic and social developments and long-term prospects on a global scale. The report also focuses on Nigeria’s economic and policy issues and analyses medium-term development challenges.

These economic and political challenges are causing Nigerian citizens to face great uncertainty, many of whom are hoping to see positive changes with the new president, Bola Ahmed Tinubu.

Nigerians are continuously seeking alternative methods to protect themselves and their families’ future, and one economical way of achieving this can be through the investment migration industry. Several factors influence Nigerians’ choices in selecting a host country’s CBI programme. Nigerians desire their dual citizenship to ensure economic and political stability in a host country that creates safety and security for both personal and business activities.

The Commonwealth of Dominica offers Nigerians opportunities that include encouraging and supporting business growth and a family-friendly environment.

Nigerians can access these opportunities through Dominica’s Citizenship by Investment (CBI) Programme and obtain dual citizenship in exchange for contributing investments towards one of the programme’s investment options. There are additional requirements when applying for dual citizenship, which include background and due diligence checks that may have additional fees applied.

Access to quality healthcare and educational facilities is important for Nigerians and their families, these facilities have international standards that offer advanced medical practices and schools that encourage further studies in Dominica or anywhere else around the world.

Dominica’s dual citizenship has one of the most affordable CBI programmes in the Eastern Caribbean region.

How do Nigerians benefit from Dominica’s CBI Programme?

Dual citizenship is a key to opening possibilities that come with Dominica’s dual citizenship, Nigerians can become part of the greater global community and increase their chances of ease of access to global markets that they were unable to previously.

Dominica is an English-speaking country, making it easier to communicate with the locals and with the Government of Dominica.

Nigerians can establish their businesses and expand their existing business ventures in Dominica. This will open more possibilities for creating permanent jobs and support local entrepreneurs with their small businesses.

Dominica offers offshore financial services to Nigerians who want to make international transactions and remittances back home. The CBI programme forms avenues for wealth management services and opportunities to protect assets and generational wealth.

The country also has many projects that are currently running through Dominica’s CBI, which will yield profitable results in their developing stages once completed, these will support the economic development of the country and improve the livelihoods of all citizens.

Nigerians can visit and live in Dominica with their family members whom they had applied for dual citizenship. Dominica is a tropical island paradise with picturesque landscapes and endless leisure activities for the whole family to enjoy.

Nigerian applicants are not required to undergo a series of exams to apply, nor do they need to live in Dominica for some time to qualify for dual citizenship.

Investment options available for dual citizenship

Nigerians can choose from the Economic Diversification Fund or Dominica’s Real Estate investment options. These investment options are also efficient for large families.

The Economic Diversification Fund (EDF) is a non-refundable contribution towards financially supporting private or public initiatives in Dominica. These initiatives include construction and development projects, renovation of hospitals, ecotourism, and agriculture. The contribution funds depend on the number of family members included in the applicant:

  • The main applicant is ₦77,000,000 (US$100,000)
  • A married couple’s contribution is ₦15,000,000 (US$150,000)
  • A family of four contributions is ₦134,000,000 (US$175,000)
  • For any additional family member under 18 years of age is ₦19,000,000 (US$25,000)
  • And for any additional family member 18 years of age and over is ₦38,000,000 (US$50,000)

Dominica’s Real Estate investment option has government-approved luxurious properties around the country that offer exceptional returns on investments. From ₦153,000,000 (US$200,000). Any real estate properties purchased must own for a minimum of three years, or five years should the future purchaser be a CBI applicant. Dominica’s real estate fees are as follows:

  • The main applicant is ₦19,000,000 (US$25,000)
  • For a family of four is ₦26,000,000 (US$35,000)
  • For a family of five is ₦38,000,000 (US$50,000)
  • For any additional family member is ₦19,000,000 (US$25,000)

Dominica has award-winning luxury properties such as the Secret Bay. The eco-luxury resort featured in Travel + Leisure as the ‘#1 Best Resort Hotel in the Caribbean, Bermuda, and the Bahamas‘ in 2022 and is expanding its amenities and villas that are expected to be available from 2025, Dominica’s CBI investors contribute to Secret Bay’s success, as it offers high returns on investments. There are other luxury resorts and villas can cater to the needs of Nigerian investors’ long-term investment goals, such as Jungle Bay, and InterContinental Dominica Cabrits Resort and Spa.

Chantal Mabanga
Commonwealth of Dominica
+44 (0) 207 318 4343
chantal.mabanga@csglobalpartners.com

GlobeNewswire Distribution ID 8873917

Cellebrite to Report Second-Quarter 2023 Financial Results on August 8, 2023

PETAH TIKVA, Israel and TYSONS CORNER, Va., July 12, 2023 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, today announced it will report its second-quarter 2023 financial results before market open on Tuesday, August 8, 2023.

Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the first quarter of 2023 and discuss its full-year 2023 outlook. Pertinent details include:

Date: Tuesday, August 8, 2023
Time: 8:30 a.m. ET
Call-In Number: 203-518-9848
Conference ID: CLBTQ223
Event URL: https://investors.cellebrite.com/events/event-details/cellebrite-q2-23-earnings
Live Webcast URL: https://edge.media-server.com/mmc/p/f896bks4

In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results. A transcript of the call will be added to this page along with access to the replay of the call.

About Cellebrite
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.

Media
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

Caution Regarding Forward Looking Statements

This document includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward looking statements include estimated financial information. Such forward looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of Cellebrite’s business are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the acceptance of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; uncertainties regarding the impact of macroeconomic and/or global conditions, including COVID-19 and military actions involving Russia and Ukraine; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; political and reputational factors related to Cellebrite’s business or operations; risks relating to estimates of market opportunity and forecasts of market growth; Cellebrite’s ability to properly manage its growth; risks associated with Cellebrite’s credit facilities and liquidity; Cellebrite’s reliance on third-party suppliers for certain components, products, or services; challenges associated with large transactions and long sales cycle; risks that Cellebrite’s customers may fail to honor contractual or payment obligations; risks associated with a significant amount of Cellebrite’s business coming from government customers around the world; risks related to Cellebrite’s intellectual property; security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions; the mishandling or perceived mishandling of sensitive or confidential information; the complex and changing regulatory environments relating to Cellebrite’s operations and solutions; the regulatory constraints to which we are subject; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the SEC on March 29, 2022,as amended on April 14, 2022 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

GlobeNewswire Distribution ID 8873303

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE). Recursion also announced plans to accelerate development of its AI foundation models for biology and chemistry, which, in collaboration with NVIDIA, it intends to optimize and distribute to biotechnology companies using NVIDIA cloud services.

“Our collaboration with NVIDIA represents two best-in-class companies coming together to help solve one of the world’s most difficult challenges, drug discovery,” said Chris Gibson, Ph.D., Co-founder and CEO of Recursion. “With our powerful dataset and NVIDIA’s accelerated computing capabilities, we intend to create groundbreaking foundation models in biology and chemistry at a scale unlike anything that has ever been released in the biological space.”

Recursion plans to utilize its vast proprietary biological and chemical dataset, which exceeds 23 petabytes and 3 trillion searchable gene and compound relationships, to accelerate the training of foundation models on NVIDIA DGX™ Cloud for possible commercial license/release on BioNeMo, NVIDIA’s cloud service for generative AI in drug discovery. NVIDIA will also help optimize and scale Recursion foundation models leveraging the NVIDIA AI stack and NVIDIA’s full-stack computing expertise. BioNeMo was announced earlier this year as a cloud service for generative AI in drug discovery, offering tools to quickly customize and deploy domain-specific, state-of-the-art biomolecular models at-scale through cloud APIs. Recursion anticipates using this software to support its internal pipeline as well as its current and future partners.

“Generative AI is a revolutionary tool to discover new medicines and treatments,” said Jensen Huang, founder and CEO of NVIDIA. “We are delighted to collaborate with Recursion’s world-class team, which is doing pioneering work in digital biology and chemistry with NVIDIA DGX and NVIDIA AI software to accelerate the development of the world’s largest biomolecular generative AI models and speed drug discovery for biotech and pharmaceutical companies.”

Recursion, through its recent acquisition of Valence Discovery, aims to accelerate the development of new technologies to feed the biopharma industry, while simultaneously democratizing access to large-scale models that have maximum impact in drug discovery.

About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward-Looking Statements
This document contains information that includes or is based upon “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the acceleration and advancement of development of AI foundation models, as well as optimizing, licensing, and distributing such models; using BioNeMo software to support Recursion’s internal pipeline and well as Recursion’s current and future industry partners; Recursion accelerating development of new technologies through its Valence Discovery acquisition; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K. All forward-looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GlobeNewswire Distribution ID 8872969

Dominica Citizenship an ideal Plan B for wealthy Kenyan investors

Roseau, July 12, 2023 (GLOBE NEWSWIRE) — As the European Union, the United Kingdom, and the United States tighten their grips on immigration policies, Kenyan investors are feeling the pinch of hyperinflation and global markets affecting their abilities to trade and travel to these countries.

Kenyan investors are making the most of the citizenship by investment (CBI) programmes in the Caribbean, more particularly in the Commonwealth of Dominica. Dominica CBI programme offers better lifestyle opportunities from quality education to healthcare system; the country has some of the best medical facilities in the world, with financial support from the CBI programme. the country’s official language is English, closely followed by Dominican Creole, which is French based, amongst local citizens.

The ‘Nature Island of the Caribbean’ is also economically and politically stable, and it is one of the fastest-growing economies in the Caribbean region. The IMF predicted that the country would exceed growth of over 4.5 per cent for 2023, including the full recovery of the tourism sector post-pandemic, as the construction of the geothermal power plant and the new international airport are projected to support Dominica’s gross domestic product (GDP), as well as the expansion of Douglas Charles Airport runway.

In May this year, Dominica Prime Minister, Honourable Dr. Roosevelt Skerrit, alongside Dominica Education Minister, Octavia Alfred, and Parliamentary Secretary, Fenella Wenham-Sheppard, had met with principles from secondary schools to discuss the education reform in the country. The discussion included possibilities to review the national education system. These discussions are to effect change towards a stronger education system to ensure all students in Dominica can access fundamental education and develop their learning experiences.

Dominica has quality healthcare facilities that align with international standards. Earlier this year, Honourable Dr. Skerrit announced changes to the country’s healthcare policy that Dominican citizens should all have access to quality medical facilities, despite their economic status and the Dominican youth between 16 to 18 years of age will have access to free medical care in the country. The Minister of Health, Wellness and Social Services of Dominica, Cassani Laville, guided a tour around the Marigot hospital and the state-of-the-art medical treatment facilities that will be available to the public from July 2023. The Marigot Hospital is another representation of the government of Dominica’s goals in becoming the world’s first climate-resilient nation.

The island is also an ideal retirement location for senior Kenyan citizens, with additional healthcare benefits. Dominica’s CBI Programme has sustained a flourishing expat community by providing opportunities in a favourable business environment, and for their families to reside in a safe and secure lifestyle.

Dominica CBI Programme

Dominica CBI Programme is one of the youngest and most affordable CBI programmes in the Caribbean region and one of the most recognised globally. A “Plan B” for Kenyans to secure their personal well-being, families and the future of their businesses, in a world filled with uncertainties. There are two distinct investment options that have favourable offerings for Kenyan investors to acquaint themselves with.

Economic Diversification Fund (EDF)

For as little as US$100,000 (estimated KSh14,000.000), the EDF is an investment option centered around socio-economic development. This is an element in the national capital mobilisation portfolio. Funds accumulated through EDF support the construction of schools, the development of medical facilities, agriculture and tourism sectors, as well construction of a national sports stadium.

Dominica is actively striving to become the world’s first climate-resilient country and fulfil sustainable development goals. Various government projects such as the planning of the geothermal power plant have gained traction in the latest developments. A Joint Venture between Dominica Geothermal Development Company and a Trinidad and Tobago company, Kenesjay Green, are driving the advancements of the geothermal and hydrogen projects in Dominica. Evolving the country’s energy into renewable energy will make Dominica one of the global exporters of green hydrogen energy, as well as propel economic development in key sectors such as tourism.

Launched in 2018, the Climate Resilience Execution Agency for Dominica (CREAD) was formed to strategically support the economic development of the country. There are 20 targets, which are separated into 6 categories that are strong communities; Robust Economy; Durable Infrastructure; Enhanced Institutional Systems; Collective Consciousness; and Protected and Sustainability Leveraged Natural and Other unique Assets. that are highlighted that Dominica aims to achieve by the year 2030.

These are noteworthy government initiatives that are tackling climate change critical to Dominica for preparedness and preservation of the natural environment around the Nature Isle of the Caribbean.

Real Estate

Kenyan investors can splurge on the Real Estate investment option that has a variety of government-approved properties that offer unique luxurious experiences for affluent Kenyans that seek decadent lifestyle choices. The minimum contribution amount is US$200,000 (estimated KSh36,000,000) towards an approved real estate property.

This investment option has the flexibility of permitting Kenyans to hold the real estate property for a period of three years from the date of citizenship approval, or for five years should the potential future buyer be a CBI applicant.

There are government fees attached to each application should the main Kenyan applicant want to include dependants, which consists of a spouse (next of kin):

  • US$25,000 (estimated KSh3,500,000) for the main applicant;
  • US35,000 (estimated KSh4,900,000) for the main applicant and up to three dependants;
  • US$50,000 (estimated KSh7,000,000) for the main applicant and up to five dependants;
  • US$25,000 (estimated KSh3,500,000) for additional dependants.

There are due diligence and processing fees applied per application.

Dominica has some of the global award-winning unique real estate properties that are on-demand and have potentially high Return on Investment (ROI) earnings for discerning Kenyan investors.

Dominica’s first government-approved real estate is the InternContinental Dominica Carbits Resort & Spa, the luxurious property is located on the beachfront of Douglas Bay that boasts sustainable elements which furnish memorable experiences that Kenyans will have like never before.

The Residences at Secret Bay are deemed the crown jewel of the Nature Isle of the Caribbean. The eco-luxury villas received recognition from Travel + Leisure, Luxury Lifestyle Magazine, Forbes and many more reputable global publications. From breathtaking views, activities for thrill seekers and luxurious dining experiences, the Secret Bay is nothing less than spectacular.

Sanctuary Rainforest Eco Resort and Spa will be located in Roseau Valley, which will offer a truly serene eco-luxury resort that morphs with nature. The resort is currently being constructed in the Morne Trois Pitons National Park and will be nestled close to Middleham Falls. The resort will have high-end luxury spa facilities and fine-dining restaurants.

Chantal Mabanga
Commonwealth of Dominica
+44 (0) 207 318 4343
chantal.mabanga@csglobalpartners.com

GlobeNewswire Distribution ID 8873103

LeddarTech and Ficosa Intensify Collaboration for Innovative Smart Parking Assistant

QUEBEC CITY, July 12, 2023 (GLOBE NEWSWIRE) — LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, is thrilled to announce the successful integration of LeddarTech’s advanced LeddarVision™ software with Ficosa’s cutting-edge surround-view camera system, along with other sensors such as radars, IMU and GPS. Ficosa is a leading global company dedicated to the research, development, production and marketing of advanced vision, safety and efficiency solutions for the automotive industry.

This significant milestone marks a major step forward in the strategic collaboration announced in December 2022 by Ficosa regarding integrating the LeddarVision software into Ficosa’s advanced driver assistance systems (ADAS) for parking. LeddarVision is a high-performance sensor fusion and perception software stack that provides extremely accurate 3D models of the vehicle’s surroundings, developed using raw data inputs from sensor systems. Integrating this software with Ficosa’s renowned vision technology unlocks the full potential of this software to enable Ficosa’s smart parking assistant for ADAS and AD.

In pursuit of their shared vision towards the consolidation of the autonomous vehicle, LeddarTech and Ficosa continue to strengthen their strategic collaboration towards developing a pioneering Intelligent Parking Assistance system, allowing even more detailed and precise perception of the surroundings. The hardware and software system architecture teams will begin equipping a car in Israel that will be used, in collaboration, to develop and demonstrate the smart parking assistance perception and driving features. Following this, two other vehicles in Europe will be added to the fleet showcasing the full software and hardware implementation for smart parking assist.

“LeddarTech is very pleased to partner in this collaboration and celebrate the success of integrating our LeddarVision software and Ficosa vision technology.” So stated Charles Boulanger, CEO of LeddarTech. “This relationship is driven by our commitment to pushing the boundaries of automotive technology by delivering cutting-edge solutions that enhance safety, efficiency and driver experiences. Our team is very excited to continue working with Ficosa on the next phase of the collaboration,” Mr. Boulanger concluded.

“At Ficosa, we strive to contribute to building a safer, more comfortable and efficient mobility of the future for everyone,” stated Josep Maria Forcadell, Chief Technology Officer at Ficosa. “In this sense, this innovative, intelligent automatic parking assistant that combines the fusion of LeddarTech’s low-level sensor and perception capabilities and Ficosa’s surround-view camera system will have a significantly positive impact, providing even more detailed and accurate perception of the environment,” Mr. Forcadell concluded.

About Ficosa

Ficosa is a leading global company dedicated to the research, development, production and marketing of advanced vision, safety and efficiency solutions for the automotive industry, with a vocation to contribute to society through its commitment to technological innovation, human values and energy efficiency. Founded in 1949 and with headquarters in Barcelona, Ficosa currently employs more than 8,500 people and has production and R&D centers and sales offices in Europe, North and South America, Asia and Africa. The Rear-View System (interior/side mirror) is Ficosa’s main, globally renowned business, which is recognized by the world’s leading original equipment manufacturers (OEMs). www.ficosa.com

Social media: Twitter @FICOSA_Int; LinkedIn Ficosa

For more information: Ficosa Communication Department
Mònica Acero: macero@llorenteycuenca.com +34 615 07 59 81
Pau Guerrero: pguerrero@llorenteycuenca.com

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech’s automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

LeddarTech is responsible for several remote-sensing innovations, with over 150 patents granted or applied for that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

GlobeNewswire Distribution ID 8871621